Article Details

ArriVent BioPharma Reports Second Quarter 2024 Financial Results - Yahoo Finance

Retrieved on: 2024-08-14 20:07:06

Tags for this article:

Click the tags to see associated articles and topics

ArriVent BioPharma Reports Second Quarter 2024 Financial Results - Yahoo Finance. View article details on hiswai:

Excerpt

ArriVent BioPharma, Inc. Clinical proof-of-concept monotherapy data for once daily, first-line firmonertinib in EGFR PACC mutant non-small cell lung ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo